CANTI, GIANFRANCO
CANTI, GIANFRANCO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
2-[125i]iodomelatonin binding in normal and neoplastic tissues
1991 B. Stankov, V. Lucini, F. Scaglione, B. Cozzi, M. Righi, G. Canti, G. Demartini, F. Fraschini
[Possible applications of living BCG and the BCG cell wall in immunotherapy]
1983 G. Canti, P. Franco, L. Ricci
[The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine)]
1983 G. Canti, P. Franco, A. Nicolin
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines
1996 S. Capaccioli, A. Quattrone, N. Schiavone, A. Calastretti, E. Copreni, A. Bevilacqua, G. Canti, L. Gong, S. Morelli, A. Nicolin
Absorption spectra of photosensitizers detected in vivo in tumor bearing mice
1995 R. Cubeddu, G. Canti, A. Pifferi, P. Taroni, G. Valentini
Absorption spectrum of hematoporphyrin derivative in vivo in a murine tumor model
1994 R. Cubeddu, G. Canti, M. Musolino, A. Pifferi, P. Taroni, G. Valentini
Action spectrum of photoactivated phthalocyanine AIS2Pc in tumor bearing mice
1992 G. Canti, D. Lattuada, E. Leroy, R. Cubeddu, P. Taroni, G. Valentini
Adoptive immunity in mice challenged with L1210/DTIC clones
1987 G. Canti, L. Ricci, O. Marelli, P. Franco, A. Nicolin
Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia
1974 A. Nicolin, G. Canti, A. Goldin
Alterazioni antigeniche indotte da dimetil-triazeno-carbossamide (DTIC) nella leucemia L1210. Attivita' citotossica in vitro di splenociti immuni.
1972 A. Nicolin, G. Canti, P. Franco, C. Riccardi
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
2017 G. Gatti, V. Lucini, S. Dugnani, A. Calastretti, G. Spadoni, A. Bedini, S. Rivara, M. Mor, G. Canti, F. Scaglione, A. Bevilacqua
Antitumor activity of photodynamic therapy, adoptive immunotherapy, and chemotherapy in experimental tumor
2004 G. Canti, A. Calastretti, R. Cubeddu, P. Tironi, G. Valentini, E. Reddi, G. Palumbo
Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors
1998 G. Canti, A. Nicolin, R. Cubeddu, P. Taroni, G. Bandieramonte, G. Valentini
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light
1994 G. Canti, D. Lattuada, A. Nicolin, P. Taroni, G. Valentini, R. Cubeddu
Antitumor therapeutic efficacy of photoactivated phthalocyanines ZnS4Pc and AlS2Pc in tumor bearing mice
1991 G. Canti, R. Cubeddu, P. Taroni, G. Valentini
Assimilation of LDL by experimental tumours in mice
1989 P. Lombardi, G. Norata, F. M. Maggi, G. Canti, P. Franco, A. Nicolin, A. L. Catapano
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity
2009 L. Ghisolfi, A. Calastretti, S. Franzi, G. Canti, M. Donnini, S. Capaccioli, A. Nicolin, A. Bevilacqua
B16 melanoma response in vivo to photochemotherapy with mitoxantrone and red light
1991 A. Andreoni, G. Canti, G. Fabbrocini, M. Mastrocinque, E. Quarto
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt
2004 L. Asnaghi, A.L. Calastretti, A.T. Bevilacqua, I. D’Agnano, G. Gatti, G. Canti, S. Capaccioli, A.N. Nicolin
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger
2003 A. Bevilacqua, M.C. Ceriani, G. Canti, L. Asnaghi, R. Gherzi, G. Brewer, L. Papucci, N. Schiavone, S. Capaccioli, A. Nicolin